Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 10,007 | -1 | 25,202 | 119 |
| Gross Profit | N/A | 10,007 | -1 | 25,202 | 119 |
| Operating Expenses | 100,757 | 100,370 | 92,195 | 98,779 | 106,169 |
| Operating Income | -100,757 | -90,363 | -92,196 | -73,577 | -106,050 |
| Other Income | 8,545 | 8,976 | 8,701 | 7,843 | 7,545 |
| Pre-tax Income | -92,212 | -81,387 | -83,495 | -65,734 | -98,505 |
| Net Income Continuous | -92,212 | -81,387 | -83,495 | -65,734 | -98,505 |
| Net Income | $-92,212 | $-81,387 | $-83,495 | $-65,734 | $-98,505 |
| EPS Basic Total Ops | -0.69 | -0.62 | -0.66 | -0.54 | -0.81 |
| EPS Basic Continuous Ops | -0.69 | -0.62 | -0.67 | -0.54 | -0.81 |
| EPS Diluted Total Ops | -0.69 | -0.62 | -0.66 | -0.54 | -0.81 |
| EPS Diluted Continuous Ops | -0.69 | -0.62 | -0.67 | -0.54 | -0.81 |
| EPS Diluted Before Non-Recurring Items | -0.69 | -0.62 | -0.67 | N/A | N/A |
| EBITDA(a) | $-102,680 | $-92,633 | $-94,490 | $-75,090 | $-106,917 |